US Patent 11186565 Aromatic compound
Patent 11186565 was granted and assigned to Takeda Pharmaceutical Company on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+173 characters)
Article
Patent abstract
Provided is a novel aromatic ring compound which may have a GPR40 agonist activity and a GLP-1 secretagogue action. A compound represented by the formula (I):
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111865650
Date of Patent
November 30, 2021
0Patent Application Number
164994320
Date Filed
March 29, 2018
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111865650
Date of Patent
November 30, 2021
0Patent Application Number
164994320
Date Filed
March 29, 2018
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11186565 Aromatic compound
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11186565
Date of patent
November 30, 2021
Patent application number
16499432
Date Filed
March 29, 2018
Patent primary examiner
Find more entities like US Patent 11186565 Aromatic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
